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Abstract 
Destruction of the cartilage matrix in joints is an 
important feature of arthritis. Proteolytic 
degradation of cartilage glycoproteins can 
contribute to the loss of matrix integrity. Human 
inter-α-inhibitor (IαI), which stabilizes the 
extracellular matrix, is composed of the light 
chain serine proteinase inhibitor bikunin and two 
homologous heavy chains (HC1 and HC2) 
covalently linked through chondroitin-4-sulfate. 
Inflammation promotes the transfer of HCs from 
chondroitin 4-sulfate to hyaluronan by tumor 
necrosis factor stimulated gene 6 protein (TSG-
6). This reaction generates a covalent complex 
between the heavy chains and hyaluronan which 
can promote leukocyte invasion. This study 
demonstrates that both IαI and the HC-hyaluronan 
complex are substrates for the extracellular matrix 
proteases ADAMTS-5 and matrix 
metalloproteases (MMP) -3, -7 and -13. The 
major cleavage sites for all four proteases are 
found in the C-terminus of HC2. ADAMTS-5 and 
MMP-7 displayed the highest activity towards 
HC2. ADAMTS- 5 degradation products were 
identified in mass spectrometric analysis of 29 out 
of 33 arthropathic patients, indicating that 
ADAMTS-5 cleavage occurs in synovial fluid in 
arthritis. After cleavage, free HC2, together with 
TSG-6, is able to catalyze the transfer of heavy 
chains to hyaluronan. The release of extracellular 
matrix-bound HC2 is likely to increase the 
mobility of the HC2/TSG-6 catalytic unit and 
consequently increase the rate of the HC transfer 
reaction. Ultimately, ADAMTS-5 cleavage of 
HC2 could alter the physiological and mechanical 
properties of the extracellular matrix and 
contribute to the progression of arthritis. 
 
 
Human inter-α-inhibitor (IαI)1 is a heterotrimer 
consisting of the serine protease inhibitor bikunin 
(UniProt P02760) and two homologous heavy 
chains referred to as heavy chain 1 (HC1) 
(UniProt P19827) and heavy chain 2 (HC2) 
(UniProt P19823) (1). Bikunin is a proteoglycan 
with an undersulfated chondroitin 4-sulfate (CS) 
chain attached to Ser-10 by a typical 
tetrasaccharide linkage (Figure 1) (2,3). The HCs 
contain both N- and O-linked glycans (4) and are 
covalently linked to the CS chain by a unique 
ester bond between the α-carboxyl group of the C-
terminal Asp residues and the C6 atoms of 
internal N-acetylgalactosamines in the C4S chain. 
This interaction is referred to as a protein-
glycosaminoglycan-protein (PGP) crosslink 
(2,3,5). HC2 is positioned closer to bikunin than 
HC1 on the CS chain, and the two HCs are 
attached 1-2 disaccharides apart (6,7). The unique 
covalent linkages between the HCs and the CS are 
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assembled intracellularly (6) and are referred to as 
PGP crosslinks (2). Bikunin CS can also link to a 
third heavy chain (HC3) (uniport Q06033) to 
form the heterodimeric pre-α-inhibitor (PαI) 
(1,2). In addition, indirect evidence based on 
sequence identity suggests that the related HC5 
(UniProt C9J2H1) (8) and possibly HC6 (UniProt 
Q6UXX5), but not HC4 (UniProt Q14624), can 
also become attached to the bikunin CS chain. 
 
IαI is produced primarily in the liver and is found 
in plasma at concentrations up to ∼0.5 mg/mL (9). 
This protein is involved in diverse biological 
processes such as ovulation, cell migration and 
inflammation (10), in addition to playing roles in 
the stabilization and remodeling of extracellular 
matrix (ECM) (11). In the ECM, IαI stabilizes 
hyaluronan (HA)-rich matrixes in a process 
requiring HC2 (12) and the tumor necrosis factor-
stimulated gene-6 protein (TSG-6) (UniProt 
P98066) (13-15). TSG-6/HC2 catalyzes two 
sequential transesterifications, thereby 
transferring HCs from the CS of IαI or PαI to HA, 
generating a covalent HC-HA complex (Figure 1) 
(16). The presence of TSG-6/HC2 and divalent 
cations is essential for this catalytic activity (12). 
The HC transfer reaction takes place during 
inflammation and inflammation-like processes in 
which TSG-6 expression is induced and 
colocalizes with IαI (17). The functional 
characteristics of HA are modified within HC-HA 
complexes, which can consequently change cell 
adhesive properties as well as matrix organization 
(18-20). A documented role of the HC-HA 
complex is involved in the formation and 
stabilization of the ECM in the expanding 
cumulus oocyte complex. The cumulus matrix 
contains HA, which becomes modified by the 
covalent attachment of HCs. Bikunin- or TSG-6-
deficient mice are unable to form a stable ECM 
around their oocytes, resulting in naked oocytes 
and female infertility (21-24). The inflammatory 
process associated with rheumatoid arthritis 
generates abundant HC-HA complexes in 
synovial fluid (11,25), which can increase the 
infiltration of leukocytes in the inflamed joints 
(20). 
 
The proteolytic destruction of articular cartilage, 
including the two major components collagen 
type II and aggrecan, is a key characteristic of 
arthritis. This tissue destruction follows aggrecan 
degradation initiated by members of the 
ADAMTS family and collagen degradation by 
matrix metalloproteinases (MMPs), leading to the 
loss of cartilage matrix (26). The expression, 
activation, inhibition, and clearance of each 
protease involved is strictly controlled (27,28). 
However, during rheumatoid arthritis (RA) and 
osteoarthritis (OA), the level of active proteases 
increases (27). The main aggrecan degrading 
enzymes that play a role during the development 
of RA and OA appear to be ADAMTS-4 and 
ADAMTS-5 (27). Only a few human proteins are 
able to cleave fibrillar collagen type II, including 
MMP-1 and MMP-13. In view of the preferred 
specificity for type II collagen and its inducible 
expression by chondrocytes, MMP-13 is 
presumed to be a key factor in the progression of 
arthritis (26). 
 
The TSG-6-catalyzed formation of HC-HA 
complexes during inflammation means that IαI is 
located in an environment where proteolytic 
activity apparently overwhelms natural protease 
regulation. We hypothesized that ADAMTS or 
MMPs involved in cartilage degradation cleave 
IαI as part of the progression of arthritis. This 
hypothesis is supported by the observation of 
truncated HCs in both arthritic cartilage and 
synovial fluid (29). In addition, ADAMTS-5 and 
IαI colocalize in equine degenerative suspensory 
ligament desmitis, and truncated versions of the 
HCs are observed (30). In the present study, we 
show that IαI is a substrate for ADAMTS-5 and 
MMP-3, -7 and -13. The main cleavage site is 
found in the C-terminus of HC2, and the 
corresponding degradation product is present in 
arthritic synovial fluid. Furthermore, we present 
data showing that the ADAMTS-5-released HC2 
retains the capacity to form an active TSG-6/HC2 
complex and is therefore able to influence arthritis 
by increasing the catalytic transfer of heavy 
chains to hyaluronan. 
 
Results 
IαI is a substrate for metalloproteinases. 
We initially tested whether IαI was proteolytically 
processed by MMP-1, MMP-3, MMP-7, MMP-
13, ADAMTS-4 or ADAMTS-5. The ability of 
the proteases to carry out cleavage was 
determined by titrating a fixed amount of IαI with 
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the different proteases at 0-20 nM (Figure 2). IαI 
was cleaved by MMP-7 or ADAMTS-5 at 0.5 nM 
(panel C and F, lane 2). MMP-3 and MMP-13 
cleaved IαI to a lesser extent, while MMP1 and 
ADAMTS-4 showed no or a very low level of 
activity towards IαI. 
To evaluate the relative rates of proteolysis, the 
amount of noncleaved IαI was measured by 
densitometry at different protease concentrations 
and normalized to nontreated IαI (Figure 2, panel 
G). From these data, it was inferred that 
ADAMTS-5 and MMP-7 are the most efficient 
proteases, while MMP-3 and MMP-13 display 
intermediate rates, and MMP-1 and ADAMTS-4 
exhibit little or no activity towards IαI. 
The proteases that cleaved IαI produced two 
initial reaction products of approximately 80 and 
116 kDa, which were further degraded at higher 
protease concentrations. The 80 and 116 kDa 
reaction product displayed migration similar to 
that of free HCs (80 kDa) and also migrated as a 
single HC linked to bikunin (120 kDa), indicating 
that the initial cut was near the C-terminal of one 
of the two IαI HCs. 
 
To further characterize the reaction products, IαI 
treated with MMP-1, MMP-3, MMP-7, MMP-13, 
ADAMTS-4, or ADAMTS-5 was analyzed by 
immunoblotting using a bikunin antiserum 
(Figure 3, panel A), an HC1 antiserum (Figure 3, 
panel B) or an antiserum recognizing both HC1 
and HC2 (HC1+2) to visualize HC2 by 
subtraction (Figure 3, panel C). As non-enzymatic 
autohydrolysis of the ester in the PGP-crosslink 
releases free full-length HCs, the protease digest 
was compared to IαI incubated for a similar time 
at a similar temperature to the protease-treated 
samples (lane 1). When the samples were probed 
with the bikunin antibody, one major product and 
full-length IαI were observed (Figure 3, Panel A). 
The migration of the major degradation product 
corresponded to bikunin linked to a single HC. 
Additional bikunin reactive products were 
observed after MMP-7 treatment (Figure 3, Panel 
A, lane 4), indicating additional cleavage sites in 
the HC-bikunin product. Bikunin remained 
associated with an HC (the 120 kDa band), 
suggesting that only one of the HCs contained a 
C-terminal cleavage site through which the 80 
kDa band was released. The HC1-specific 
antibody revealed two major bands at 80 and 116 
kDa (Figure 3, Panel B). These bands were also 
observed after autohydrolysis of the PGP 
crosslink and represent free HC1 (80 kDa) and 
HC1-bikunin (Figure 3, panel B, lane 1). 
However, the intensity of the HC1-bikunin band 
was significantly increased after MMP3, MMP-7, 
MMP-13 or ADAMTS-5 treatment (Figure 3, 
panel B, lanes 3, 4, 5 and 7), indicating that the 
HC-bikunin product contains HC1-bikunin 
(Figure 3, panel B, lane 6). The digest analyzed 
with the HC1+2 antibody exhibited the HC-
bikunin species, the free HCs, and some minor 
degradation products after MMP-3, MMP-7 or 
MMP-13 treatment (Figure 3, panel C). These 
additional degradation products all present lower 
MWs than the full-length HCs and are not 
observed when an anti-HC1 antibody is used, 
indicating that these products are HC2 related. 
Moreover, the free HC2 band observed after 
autohydrolysis (Figure 3, panel C, lane 1) was 
reduced or disappeared after treatment with 
MMP3, MMP-7, MMP-13 or ADAMTS-5 
(Figure 3, panel C lanes, 3, 4, 5 and 7). These data 
show that the initial and major cleavage site in IαI 
is within the C-terminus of HC2. After cleavage, 
the released HC2 most likely co-migrates with 
HC1. 
 
The C-terminus of HC2 is susceptible to 
proteolysis 
An N-terminomics approach was applied to 
identify the neo N-termini after protease 
treatment. Purified IαI was titrated with MMP-3, 
MMP-7, MMP-13 or ADAMTS-5, and all N-
termini were acetylated to label the neo N-
termini. The labeled samples were digested with 
either trypsin or a combination of trypsin and the 
endoprotease GluC and subsequently analyzed by 
LC-MS/MS. N-termini originating from MMP or 
ADAMTS cleavage events were identified as 
acetylated N-termini, which were not observed in 
a control sample of nontreated IαI (Table 1). To 
verify the N-terminomics results, we determined 
the N-terminal sequence by Edman degradation 
of the major HC-bikunin product after transfer to 
PVDF membranes (Figure 2 and Table 1). In line 
with the previous results, all proteases preferred a 
substrate site in the C-terminus of HC2. 
Significantly, residues Ser-625 to Ala-628 were 
particularly susceptible to proteolysis. At this site, 
MMP-13 uniquely cleaved S625/M626; MMP-3 
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and MMP-7 cleaved M626/L627; and ADAMTS-
5 cleaved the L627/A628 peptide bond (Figure 4). 
In addition to the main cleavage sites, there are 
two other regions in HC2 (308-331 and 436-438) 
that are susceptible to cleavage to a minor degree. 
The 420-438 region has previously been shown to 
be exposed and available for transglutaminase 
crosslinking (31). 
 
HC2 is a substrate for MMP-3, MMP-7, MMP-
13 and ADAMTS-5 when covalently linked to 
HA 
It has previously been shown that MMP-3, 
MMP13, ADAMTS-5 and IαI are present in the 
cartilage and synovial fluid of arthropathic 
patients (27,29,32,33). While these proteases are 
able to act directly on IαI, the major IαI-related 
substrate is most likely the HC-HA complex, 
which shows increased abundance in arthritic 
patients. Consequently, we analyzed whether the 
proteases were able to cleave the HCs when 
linked to HA (Figure 5). Preincubation with IαI 
(Figure 5, lane 1), TSG-6 and a short HA 
oligomer was performed for 4 hours (Figure 5, 
lane 3) before proteases were added to the sample 
(Figure 5, lane 4-7). Subsequently, all samples 
were incubated for 16 hours (lanes 3-7) and 
analyzed by SDS-PAGE and immunoblotting 
using antibodies recognizing both HC1 and HC2. 
IαI, TSG-6 and HA oligomers generated two 
bands corresponding to a single HA-oligomer 
linked to either HC1 or HC2 (Figure 5, lane 3). 
The four proteases that cleaved IαI (MMP-3, 
MMP-7, MMP-13 and ADAMTS-5) also 
specifically cleaved HC2 when transferred to HA, 
as demonstrated by a significant reduction in the 
HC2-HA band (Figure 5, lane 4-7). 
 
Cleavage of HC2 by ADAMTS-5 is identified in 
synovial fluid from arthropathic patients as the 
major degradation product. 
Our in vitro analysis revealed that IαI is a 
substrate for MMP-3, MMP-7, MMP-13 and 
ADAMTS-5, as they all cleave HC2 within 3 
residues, with P1 located at Ser625 (MMP-13), 
Met626 (MMP-3 and -7) or Leu627 (ADAMTS-
5). These proteases are known to be involved in 
tissue degradation during pathological conditions 
such as RA and OA. In addition, inflammation 
increases the number of HCs linked to HA. To 
determine whether HC2 is cleaved by MMPs or 
ADAMTS during inflammatory conditions in 
vivo, a mass spectrometry-based assay was 
employed. The cleaved C-terminal HC2 peptide 
was isolated after hydrolysis of the PGP crosslink 
in synovial fluid from 10 OA patients, 9 RA 
patients, and 14 spondyloarthropathy (SpA) 
patients and identified by mass spectrometry 
(Table 2). The ADAMTS-5 cleavage site was 
detected in 29 out of the 33 patient samples (Table 
2) (OA, 9 out of 10; RA, 8 out of 9; and SpA, 12 
out of 14). The ADAMTS-5 degradation product 
was found in all types of arthritic synovial fluid 
examined. In 3 out of the 33 samples, we observed 
the MMP-3/-7 degradation product (2 RA and 1 
SpA), while we did not identify the MMP-13 
degradation product in any of the synovial fluid 
samples. The in vivo identification of the 
ADAMTS-5 reaction product in synovial fluid 
from arthropathic patients supports the relevance 
of the observation to the pathogenesis of 
arthropathy. 
 
ADAMTS-5 releases functional HC2 from the 
HA-binding articular cartilage scaffold. 
We have previously shown that complex 
formation between TSG-6 and HC3 depends on 
HC2 (12). While the PGP crosslink is necessary 
for transesterification, HC2 in its free form can 
induce complex formation between 
glycosaminoglycan (HA or CS)-bound HCs and 
TSG-6 (12). To determine whether HC2 released 
by ADAMTS-5 proteolysis was able to induce 
complex formation between HCs and TSG-6, we 
incubated TSG-6 with IαI cleaved by ADAMTS-
5 (Figure 6). Following incubation with 
ADAMTS-5, all the HC2 was cleaved (Panel A, 
lane 2). After incubation with TSG-6, the samples 
were separated by SDS-PAGE and visualized by 
immunoblotting using a TSG-6 antibody (Panel 
B). TSG-6 incubated with IαI usually forms 
complexes with both HCs (lane 4). When IαI was 
preincubated with ADAMTS-5, only a single 
complex corresponding to HC1-TSG-6 was 
apparent. We cannot exclude the possibility that 
HC1-bikunin is able to form a complex with TSG-
6 independent of HC2. Consequently, ADAMTS-
5-cleaved HC2 was isolated and incubated with 
PαI and TSG-6 (Panel C). A previous study 
showed that TSG-6 and PαI alone are unable to 
form the HC3-TSG-6 complex (lane 4). However, 
when purified and cleaved HC2 was included, the 
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HC3-TSG-6 complex was observed (lane 5). 
Since HC2 is required for complex formation, we 
conclude that ADAMTS-5-released HC2 retains 
the ability to induce the HC3-TSG-6 complex. 
 
Discussion 
In this study, we demonstrated that IαI is a 
substrate of ADAMTS-5 in vivo. HC2 was 
cleaved in vitro at an enzyme concentration (2 
nM) equivalent to the physiological ADAMTS-5 
concentration (34). In addition, MMP-3, -7 and -
13 cleaved IαI in vitro. The major cleavage sites 
of all of these proteases are located within 3 
residues (VIS625/MMP-13M/MMP-3/7L/ADAMTS-
5AQGSQ). After the initial cleavage, additional 
N- and C-terminal cleavage may occur. To 
identify degradation in vivo, we used a novel 
isolation technique exploiting the ability to 
selectively release HCs from HA by hydrolyzing 
the PGP crosslink using 100 mM NaOH (35). In 
synovial fluid from SpA, RA, and OA patients, 
we were able to identify the ADAMTS-5 cleaved 
C-terminus of HC2 in 33 out of 37 patient 
samples. 
 
In general, MMPs prefer to cleave peptide bonds 
preceding residues containing hydrophobic side 
chains (P1’: Leu, Ile, Met, Phe, or Tyr) and those 
with a proline as the third residue prior to the 
cleavage site (P3) (36). For both MMP-3 and 
MMP-7, Leu is favored in the P1’ position. Based 
on the substrate cleavage sites reported in 
MEROPS (37), the frequencies of Leu at P1’ for 
MMP-3 and MMP-7 are 0.28 and 0.55, 
respectively, which is in agreement with the 
cleavage site in HC2. MMP-13 also shows 
specificity towards Leu (frequency 0.34), while 
the frequency of Met at P1’, as observed in HC2, 
is only 0.08. The best-described ADAMTS-5 
substrate is aggrecan, containing 5 sites, all of 
which harbor a Glu residue at P1 and a Gly, Ala, 
or Leu residue at P1’. Among the 38 ADAMTS-5 
substrate sites reported in MEROPS(37), the 
frequency of Glu at P1 is 0.21, while Leu is only 
observed at 5% of the substrate sites in HC2. 
However, the frequency of Ala at P1’ is 0.18 and 
is only superseded by that of Gly, with a 
frequency of 0.21. The amino acid sequence of 
the HC2 region susceptible to proteolysis is in 
agreement with the specificity of MMP-3 and 
MMP-7, while the preferred substrate recognition 
residues of MMP-13 and ADAMTS-5 are absent. 
In addition, the location of the cleavage sites 
indicates that CS could be involved in facilitating 
the proteolytic event. A hypothesis supported by 
a previous study showing that the activity of 
ADAMTS-4 and -5 depends on the chondroitin 
sulfate chains in aggrecan (38). 
 
In inflammatory conditions such as arthritis, 
increased TSG-6 expression facilitates the 
generation of HC-HA complexes (11). In 
addition, MMP activity is increased, and the HC-
HA complexes therefore become likely to 
undergo to metalloprotease degradation. Indeed, 
the in vitro results showed that the HC-HA 
complexes were substrates for MMP-3, MMP-7, 
MMP-13, and ADAMTS-5. Furthermore, it is 
known that MMP-13 and ADAMTS-5 are 
involved in tissue degradation during 
osteoarthritis(27,36), indicating that ADAMTS-5 
might be responsible for the observed in vivo 
processing of HC2 in the joints of OA, RA, and 
SpA patients. In a previous study, truncated 
versions of the HCs were detected in synovial 
fluid and osteoarthritic cartilage. It was suggested 
that they might have been synthesized by the 
chondrocytes (29). Alternatively, these truncated 
HC species, which migrated with apparent MWs 
between 55-75 kDa, might result from ADAMTS-
5 or MMP proteolysis, as described in the present 
study. 
 
The ADAMTS-5-mediated release of HC2 from 
either HA or IαI is likely to have a number of 
functional implications (Figure 7). This HC-HA 
processing may change the stability as well as the 
cell binding properties of HA with multiple 
downstream consequences (20,23). In addition, 
the bioavailability of HC2 and TSG-6 will be 
affected as HC2 is released from the HA-coated 
ECM surface (Figure 7). This is likely to affect 
the kinetics of the HC transfer reactions and, thus, 
the physical properties of HA. In synovial fluids 
from RA patients, up to 5 HCs are found attached 
to a single HA chain of 2 x 106 Da. This covalent 
HC modification influences the propensity of HA 
to aggregate compared to unmodified HA and 
may, thus, alter HC-HA matrix stabilization (25). 
In addition, the transfer of HCs to HA in arthritis 
(11) increases the binding of HA to its major cell 
surface receptor, CD44, on leukocytes(20), 
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although it is not clear how this might influence 
the pathology of arthritis (15,39). 
 
One of the most significant physiological 
functions of the HCs is stabilization of the ECM 
in the expanding cumulus oocyte complex. 
During the maturation of the oocyte, the 
granulosa cells in the follicle expand the ECM 
and form an HC-dependent HA-rich matrix that is 
essential for fertilization (21-23). In a study 
analyzing the expression of ADAMTS-5 in the 
cumulus oocyte complex, ADAMTS-5 was 
expressed by granulosa cells in most follicles 
(40). However, after ovulation, ADAMTS-5 
expression was absent in the released oocytes, 
while it was still expressed during follicular 
atresia. The ovulation-dependent regulation of 
ADAMTS-5 may therefore govern the formation 
of the HC-HA-rich matrix by cleaving and, thus, 
releasing HC2 from the ECM. Matured follicles 
that are not ovulated undergo atresia (apoptosis), 
and ADAMTS-5 may participate in this process 
by dissolving the hyaluronan-rich matrix, offering 
an explanation and role for the continued 
expression of ADAMTS-5. 
 
It has been shown previously that the HC-HA 
complex mediates cellular adhesion to the HA-
rich matrix (18-20). This interaction is regulated 
by thrombin-induced cleavage of HC1 and 
reduces leukocyte binding to an HA-rich matrix 
during inflammation (41). The ADAMTS-5-
mediated release of HC2 could have a similar 
effect and, hence, regulate leukocyte adhesion 
and migration by dissolving the HC-HA matrix. 
An additional study has shown that the HCs of IαI 
inhibit the classical pathway of the complement 
system, with HC2 acting as the most potent 
inhibitor (42). We speculate that the release of 
HC2 acts as a mechanism for local control of the 
activation of the complement system. In 
conclusion, the release of HC2 by ADAMTS-5 
could influence inflammation by regulating both 
leukocyte infiltration and complement activation. 
 
In conclusion, the data presented in this study 
show that HC2 from IαI is a substrate for matrix-
degrading proteases, with ADAMTS-5 being the 
most efficient. Our in vitro data are supported by 
the identification of the ADAMTS-5 degradation 
product in synovial fluids from arthritic patients. 
The release of HC2 can influence both the 
mechanical and physiological properties of the 
ECM. 
 
Experimental procedures 
Materials – IαI and PαI were purified from human 
plasma obtained from Aarhus University 
Hospital, Skejby, Denmark (1). Human TSG-6 
was expressed in insect cells and purified as 
previously described (43). MMP-1, -3, -7, and -13 
(44-46), ADAMTS-4 lacking the C-terminal 
spacer domain and ADAMTS-5 lacking the C-
terminal thrombospondin domain(38) were 
expressed, activated and purified as previously 
described. HA oligomers were produced and 
purified as previously described (12). Briefly, a 
13-disaccharide-long HA oligosaccharide was 
generated and purified following limited 
chondroitinase ABC digestion of HA. 
Subsequently, HA was fractionated by anion 
exchange and desalted by size exclusion 
chromatography. All reagents and chemicals were 
from Sigma-Aldrich/Merck unless otherwise 
stated. 
 
SDS-PAGE and immunoblotting - Samples were 
boiled in SDS sample buffer in the presence of 50 
mM dithiothreitol (DTT). SDS-PAGE was 
performed in 5-15% gradient gels (10 cm × 10 cm 
× 0.15 cm) using the glycine/2-amino-2-methyl-
1,3-propanediol/HCl system (47). The gels were 
either stained for protein using Coomassie blue or 
electroblotted to an Immobilon-P membrane (48). 
Immunoblotting was carried out using standard 
protocols and a rabbit anti-bikunin (3), rabbit anti-
TSG-6 (49) or rabbit anti-HC antibody (3) as the 
primary antibody. The secondary antibody was 
goat anti-rabbit IgG-Peroxidase. The membranes 
were developed using ECL reagents (GE 
Healthcare). Densitometry measurements of the 
Coomassie blue-stained gels were performed 
using ImageJ 1.52 (NIH, USA)	(50). 
 
Proteolytic digestion of IαI– Fixed concentrations 
of IαI (1.1 µM) were incubated with either fixed 
(20 nM) or increasing amounts of activated 
MMP-1, MMP-3, MMP-7, MMP-13, ADAMTS-
4 or ADAMTS-5 (0, 0.5, 2, 10, 20 nM). All 
samples were dissolved in 50 mM Tris-HCl, 150 
mM NaCl, and 10 mM CaCl2 pH 7.6 
supplemented with 0.05% Brij-35. The samples 
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were incubated for 16 hours at 37°C and analyzed 
by either LC-MS/MS or SDS-PAGE. 
 
Degradation of HA-associated HCs – IαI (2.5 
µg), TSG-6 (0.8 µg) and 25 µg of HA oligomers 
(HA14) were incubated for 4 hours at 37°C in 50 
mM Tris-HCl, 100 mM NaCl, 1 mM MgCl2 pH 
7.4. Subsequently, MMP-3, MMP7, MMP13 or 
ADAMTS-5 was added to a final concentration of 
20 nM. Additionally, the samples were 
supplemented with 0.05% brij-35 and 10 mM 
CaCl2. The samples were incubated for 16 hours 
at 37°C before they were analyzed by SDS-PAGE 
and immunoblotting using an anti-HC1+2 
antibody. 
 
Isolation of ADAMTS-5 cleaved HC2 – Limited 
proteolysis of IαI using 160 nM ADAMTS-5 
completely released HC2 from IαI, as confirmed 
by western blotting. The released HC2 was 
separated from HC1-bikunin by anion exchange 
chromatography using a Mono Q 4.6/100 PE 
column (GE Healthcare) equilibrated in 20 mM 
Tris-HCl, pH 7.4. Proteins were eluted using a 
linear gradient from 0 to 0.6 M NaCl over 60 min 
with a flow rate of 1 ml/min. Fractions containing 
HC2 were visualized by SDS-PAGE and 
identified by MS. Fractions containing cleaved 
HC2 were pooled and concentrated by 
ultrafiltration (30 kDa, Amicon). 
 
HC·TSG-6 complex formation – IαI (0.6 µg), IαI 
(0.6 µg) pretreated with ADAMTS-5 (160 nM) or 
PαI (0.6 µg) was incubated with 0.2 µg of TSG-6 
for 2 hours at 37°C. The samples were dissolved 
in 50 mM Tris-HCl, 100 mM NaCl, pH 7.4. To 
verify the activity of cleaved HC2, purified HC2 
was incubated with TSG-6 and PαI under the 
same conditions. The samples were analyzed by 
SDS-PAGE and immunoblotting using an anti-
TSG-6 antibody. 
 
N-terminal sequencing - Automated Edman 
degradation was performed in a PPSQ-31B 
protein sequencer (Shimadzu Biotech) with in-
line PTH analysis in an LC-20AT HPLC system 
equipped with a CTO-20A column heater and an 
SPD20A UV detector (Shimadzu Biotech). SDS-
PAGE-separated samples were transferred to 
PVDF membranes (48) and applied to TFA-
treated glass fiber membranes that had been 
precycled with polybrene (Shimadzu Biotech). 
Data were recorded using Shimadzu PPSQ-31B 
software, and the sequence was determined by 
visual inspection of the UV 269 nm 
chromatograms. 
 
Identification of cleavage sites by N-terminomics 
- IαI was titrated with increasing amounts of 
MMP-3, MMP-7, MMP-13 or ADAMTS-5 (0, 2, 
10, 20 nM) for 4 hours at 37°C in 50 mM 
phosphate, 100 mM NaCl, 1 mM MgCl2, 0.05% 
brij-35 and 10 mM CaCl2 pH 7.4. The reactions 
were quenched by adding EDTA to a final 
concentration of 10 mM. Subsequently, all N-
termini and lysine residues were acetylated using 
10 mM sulfo-NHS-acetate. The samples were 
incubated for 60 min at 22°C before the reaction 
was quenched with 150 mM Tris-HCl, pH 7.4. 
The sample was denatured and reduced in 6 M 
urea containing 5 mM DTT for 1 hour and 
subsequently alkylated with 15 mM 
iodoacetamide for 1 hour. The urea concentration 
was reduced by diluting the sample 8 times with 
50 mM NH4HCO3. The samples were treated with 
either trypsin alone or with endoproteinase GluC 
followed by trypsin. The proteases were added at 
a w/w ratio of 1:20, and the samples were 
incubated for 16 hours at 37°C. The digested 
samples were analyzed by LC-MS/MS. 
 
Qualitative identification of degradation products 
in arthropathic patient samples - Synovial fluid 
from 10 OA patients, 9 RA patients and 14 SpA 
patients was collected at Aarhus University 
Hospital and the Musculoskeletal Tissue Bank of 
the University of Liverpool, UK. The collection 
of patient samples was approved by the Danish 
Data Protection Agency (2011-41-6863), the 
Regional Ethics Committee, DK (1-10-72-291-
12), and the National Research Ethics Service, 
UK (15/NW/0661). The subjects’ written consent 
was obtained according to the Declaration of 
Helsinki. 
 
Proteins and hyaluronic acid were precipitated by 
adding 9 volumes of ice-cold 90% ethanol, 
followed by incubation at -18°C for 16 hours. The 
pellet was isolated by centrifugation at 17.000 x g 
for 30 min. The C-terminal product resulting from 
the in vivo cleavage of HC2 was released from 
HA and/or CS by hydrolyzing the ester bond with 
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100 mM NaOH for 30 min on ice. Subsequently, 
undigested protein and HA were removed by 
precipitation with TCA and centrifugation at 
17.000 x g for 30 min. The supernatant containing 
the potential C-terminus of HC2 was analyzed by 
LC-MSMS. 
 
LC-MSMS analysis 
Mass spectrometry –All samples were desalted by 
micropurification using Empore™ SPE Disks of 
C18 octadecyl packed in 10 µl pipette tips (51). 
LC-MS/MS was performed using either an 
EASY-nLC 1000 system (Thermo Scientific) 
connected to a QExactive+ Hybrid Quadrupole-
Orbitrap Mass Spectrometer (Thermo Scientific) 
through a Nanospray Flex™ Ion Source (Thermo 
Scientific) or an Eksigent nanoLC 415 system 
(Sciex) connected to a TripleTOF 6600 mass 
spectrometer (Sciex) equipped with a NanoSpray 
III source (Sciex). Peptides were dissolved in 
0.1% formic acid, injected, trapped and desalted 
in a ReproSil-Pur C18-AQ trap column (2 cm x 
100 µm inner diameter packed in-house with 3 
µm resin (Dr. Marisch GmbH, Ammerbuch-
Entringen, Germany). The peptides were eluted 
from the trap column and separated in a 15-cm 
analytical column (75 µm inner diameter) packed 
in-house in a pulled emitter with ReproSil-Pur 
C18-AQ 3 µm resin (Dr. Marisch GmbH, 
Ammerbuch-Entringen, Germany). Peptides were 
eluted using a flow rate of 250 nl/min and a 50 
min gradient from 5% to 35% phase B (0.1% 
formic acid and 90% acetonitrile or 0.1% formic 
acid, 90% acetonitrile and 5% DMSO). The 
collected MS files were converted to generic 
Mascot format (MGF) using the SCIEX MS Data 
Converter beta 1.1 (Sciex) or RawConverter (52). 
 
Analysis of MS data - The data were searched 
against IαI sequences using a local Mascot search 
engine and the following settings: MS error 
tolerance of 10 ppm, MS/MS error tolerance of 
0.1 Da, semitryptic, iodoacetamide as fixed 
modification. Oxidized Met and glycosylation 
(Hex HexNAc NeuAc) of Ser and Thr were 
selected as variable modifications. Additional 
settings for the identification of N-termini using 
sulfo-NHS-acetate were fixed acetylation of Lys 
and variable acetylation of the peptide N-
terminus. 
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The Abbreviations used are as follows: IαI, Inter-α-inhibitor; HC1, heavy chain 1; HC2, heavy chain 2; 
C4S, chondroitin 4-sulfate; ECM, extracellular matrix; TSG-6, tumor necrosis factor-stimulated gene-6 
protein; ADAMTS, a disintegrin and metalloproteinase with thrombospondin type 1 motifs; MMP, matrix 
metalloproteinase; HA, hyaluronan (HA). 
 
 
Table 1 Identification of metalloproteinase cleavage sites in IαI 
Concentration (nM) 2 10 20 Edman sequencing2 
MMP3 
 
HC2: 627 HC2: 313 627 L_QGSQVLE__PP 
(HC2) 
MMP7 HC2: 3081 313 397 627 
HC1: 461  
HC2: 308 313 397 432 
436 511 571 574 627 
HC1: 399 461 572 
HC2: 65 308 313 362 
397 432 437 438 511 
574 627 
HC1: 22 367 399 572 
LAQG_QVLES_PP 
(HC2) 
MMP13 
 
HC2: 438 HC2: 308 313 438 626 
HC1: 461 572 
ML_QGSQVLE__P 
(HC2) 
ADAMTS5 HC2: 313 437 628 HC2: 313 330 436 437 
628 
HC2: 305 313 314 330 
403 436 437 628 
AQGSQVLES_PPP 
(HC2) 
1Bold residues are major cleavage sites based on the intensity of the MS signal. 
2Thr 637 is glycosylated and is not identified by Edman degradation 
 
 
Table 2 Identification of HC2 cleavage mediated by ADAMTS-5 or MMPs in patients with arthritis 
Arthropathy Number of 
patients 
Number of 
Patients 
with 
ADAMTS-5 
product 
Number of 
Patients 
with MMP-
3/-7 product 
Male/Female Age 
(Average) 
BMI# 
(Average) 
Osteoarthritis 10 9 0 5/5 25-79 (55.8) 15.8-33.6 
(26.8) 
Rheumatoid arthritis 9 8 2 2/7 31-79 (53.6) 18.4-33.8 
(23.6) 
Spondyloarthropathy 14 12 1 7/7 21-77 (46.8) 21.6-38.1 
(26.9) 
Total 33 29 3 14/19 21-79 (51.1) 18.4-38.1 
(25.9) 
#Information not available for all patients (OA 8/10; RA 8/9; SpA 10/14) 
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Figure 1. Overview of the human IαI and TSG-6 mediated HC transfer. IαI is composed of bikunin and 
two homologous heavy chains (HC1 and HC2) (Top). The HCs are covalently linked to the CS chain by a 
unique ester bond between the C-terminus and N-acetylgalactosamines in the CS chain (insert) referred to 
as a PGP-crosslink (2,3,5). In the ECM, IαI stabilizes hyaluronan (HA)-rich matrixes in a process requiring 
TSG-6 expressed during inflammatory disease states (13-15). TSG-6 catalyzes the transfer of HCs from IαI 
to HA, generating covalent HC-HA complexes (16). Pre-α-inhibitor (PαI) is composed of bikunin linked to 
HC3 (bottom) (1,2). The presence of HC2 is essential for the TSG-6-mediated transfer of HC3 to HA (12). 
The HC transfer reaction takes place in the presence of divalent cations and when the TSG-6 and bikunin 
proteins colocalize, e.g., during inflammation (17). The transfer of HC to HA changes the characteristics of 
the HA matrix and affects cell adhesive properties and matrix organization (18-20). 
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Figure 2. IαI is a substrate for MMP-3, MMP-7, MMP-13 and ADAMTS-5. A fixed amount of IαI was 
incubated with increasing amounts of the indicated proteases for 16 hours at 37°C before being analyzed by 
SDS-PAGE and stained with Coomassie blue (A-F). The concentration of IαI was 0.9 µM, and the 
concentration of the protease was 0, 0.5, 2, 10 and 20 nM (lanes 1 to 5). The protease alone at 20 nM was 
loaded as a control (lane 6). MW size markers are indicated on the left side (kDa). The schematics on the 
right side of the gels show the migration of intact IαI, HC-bikunin, HC2 and HC1 alone. In lane 1, IαI 
appears together with HC-bikunin and free HCs as a result of nonenzymatic autohydrolysis of the ester in 
the PGP-crosslink. The relative rate of IαI proteolysis by the tested proteases was evaluated by densitometry 
(G). The amount of noncleaved IαI at different protease concentrations was normalized to the IαI control 
(lane 1). The error bars represent the standard deviation of at least three experiments. In conclusion, these 
data show that MMP-3, MMP-7, MMP-13 and ADAMTS-5 are able to cleave IαI, which is demonstrated 
by the progressive reduction of the IαI level, accompanied by the occurrence of proteolytic degradation 
products. 
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Figure 3. HC 2 contains the initial cleavage site. IαI was treated with the indicated proteases. The products 
were analyzed by SDS-PAGE and visualized by immunoblotting using an antibody recognizing bikunin 
(A), HC1 (B) or HC1+2 (C). Due to the hydrolysis of the PGP-crosslink, IαI alone (lane 1) contained some 
HC-bikunin and free HCs when analyzed by SDS-PAGE. The schematics on the right side of the gels show 
the migration of intact IαI, HC-bikunin, HC2 and HC1 alone. In the anti-bikunin blot (A), MMP-3, MMP-
7, MMP-13, and ADAMTS-5 treatment (lanes 3-5 and 7) reduced the level of IαI and increased the amount 
of a product migrating similarly to HC-bikunin. Using anti-HC1 (B), we similarly observed an increase in 
HC-bikunin, while the intensity of free HC1 appeared to be stable (lanes 3-5 and 7). The anti-HC1+2 blot 
(C) revealed a reduction in the intensity or a complete absence of the HC2 band (lanes 3-5 and 7). The 
variation in the intensity of the HC1-containing bands between panels B and C is a result of antibody 
efficiency and exposure time and does not represent variations in the amount of HC1. The proteolytic 
digestion of IαI was repeated more than ten times, while immunoblotting was repeated two times for panels 
A and B and more than 6 times for panel C. Taken together, the observations indicate that the major MMP-
3, MMP-7, MMP-13, and ADAMTS-5 cleavage sites are located in the C-terminus of HC2. 
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Figure 4. Overview of the neo-N-termini in heavy chain 2 after proteolytic treatment. Summary of the 
N-terminal sequencing results and LC-MS/MS data (Table 1). The schematics represent HC2, with the 
location of the neo NH3-termini indicated with vertical lines, and the relevant protease is indicated. The 
major and initial cleavage sites are located in the C-terminus close to the PGP-crosslink. Cleavage in the C-
terminus of HC2 releases HC2 from the IαI complex and is likely to facilitate HC2/TSG-6 activity and 
increase the rate of the HC transfer reaction. 
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Figure 5. ADAMTS-5, MMP-3, MMP-7 and MMP-13 are able to cleave HC2 when covalently linked 
to HA. IαI (lane 1) was incubated with TSG-6 alone (lane 2) or with both TSG-6 and HA oligomers (lane 
3). After 4 hours at 37°C, the protease was added to the HA-containing sample (lanes 4-7), which was then 
incubated for 16 hours in parallel with the control sample (lane 3). All samples were analyzed by SDS-
PAGE and immunoblotting using an anti-HC antibody. Schematics of the subunit compositions of the bands 
are shown on the right side of the gel. As expected, the migration of the HCs transferred to HA by HC2/TSG-
6 (lane 3) was slower than that of the free HCs. The migration of the free HCs is shown in lane 1 as a result 
of nonenzymatic autohydrolysis of the ester in the PGP crosslink. Following proteolysis (lanes 4-7), the 
bands corresponding to HC2-HA are reduced or absent. The degradation products can be observed following 
MMP-13 or ADAMTS-5 treatment (lanes 6-7). MMP-3 and 7 (Lanes 4 and 5) apparently cleave HC2 into 
fragments that are not recognized by the antibody. The data represent four experimental repeats. These data 
show that HC2 crosslinked to HA still acts as a substrate for MMP-3, MMP-7, MMP-13 and ADAMTS-5. 
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Figure 6. C-terminally truncated HC2 maintains the ability to induce HC-TSG-6 complex formation. 
Panel A) IαI was pretreated with ADAMTS-5 to release all HC2. IαI (lane 1) and IαI treated with ADAMTS-
5 (lane 2) were incubated at high pH to hydrolyze the ester in the PGP crosslink. The samples were analyzed 
by SDS-PAGE and visualized by immunoblotting using an anti-HC1+2 antibody. After ADAMTS-5 
treatment, no full-length HC2 was present (lane 2). Panel B) TSG-6 (seen alone in lane 1) was incubated 
with either IαI (lane 4) or IαI pretreated with ADAMTS-5 (lane 5). The samples were analyzed by SDS-
PAGE and immunoblotting using an anti-TSG-6 antibody. IαI alone and IαI pretreated with ADAMTS-5 
are shown in lanes 2 and 3, respectively. Prior to ADAMTS-5 treatment, both HC1 and HC2 form a complex 
with TSG-6 (lane 4). Significantly, following ADAMTS-5, cleaved HC2 remains able to catalyze the 
formation of the HC1-TSG-6 complex. Panel C) To verify that cleaved HC2 is able to mediate HC-TSG6 
complex formation, cleaved HC2 was isolated after ADAMTS-5 treatment with IαI. Purified HC2 was used 
to evaluate complex formation between TSG-6 and HC3. TSG-6 (see alone in lane 1) was incubated with 
PαI (lane 4) or PαI and purified cleaved HC2 (lane 5). The samples were analyzed by SDS-PAGE and 
immunoblotting using an anti-TSG-6 antibody. It is only in the presence of HC2 that TSG-6 and HC3 from 
PαI form the HC3-TSG-6 complex. PαI and purified HC2 are shown in lanes 2 and 3, respectively. Since 
complex formation between TSG-6 and HC3 is HC2 dependent, these data show that the ADAMTS-5-
released HC2 is still functional. 
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Figure 7. Potential consequences of ADAMTS-5-mediated HC2 release from HA. ADAMTS-5-
mediated release of HC2 may change the stability and cell-binding properties of HA. In addition, it has 
previously been shown that the transfer of HCs to HA increases the binding of HA to its primary cell surface 
receptor, CD44, on leukocytes (20). Consequently, the release of HC2 may inhibit leukocyte adhesion to 
the HA-rich matrix. HC2 also affects complement activation(42), and the ADAMTS-5-mediated release of 
HC2 may therefore provide a mechanism for local regulation of the immune response. Furthermore, the 
bioavailability and mobility of the HC2 TSG-6 complex will be affected when HC2 is released from HA in 
the ECM. 
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